30 related articles for article (PubMed ID: 30206985)
1. Identification of potential leads against 4-hydroxytetrahydrodipicolinate synthase from Mycobacterium tuberculosis.
Rehman A; Akhtar S; Siddiqui MH; Sayeed U; Ahmad SS; Arif JM; Khan MK
Bioinformation; 2016; 12(11):400-407. PubMed ID: 28293071
[TBL] [Abstract][Full Text] [Related]
2. Computational finding of potential inhibitor for Cytochrome P450 Mono-oxygenases Enzyme of Mycobacterium tuberculosis.
Sharma A; Subbias KK; Robine O; Chaturvedi I; Nigam A; Sharma N; Chaudhary PP
Bioinformation; 2012; 8(19):931-7. PubMed ID: 23144553
[TBL] [Abstract][Full Text] [Related]
3. From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning.
Li LS; Yang L; Zhuang L; Ye ZY; Zhao WG; Gong WP
Mil Med Res; 2023 Nov; 10(1):58. PubMed ID: 38017571
[TBL] [Abstract][Full Text] [Related]
4. Repurposing of drugs against methyltransferase as potential Zika virus therapies.
Shukla R; Chandra A; Kumar A; Kandpal P; Avashthi H; Goel VK; Qamar I; Singh N; Kelvin DJ; Singh TR
Sci Rep; 2023 May; 13(1):7870. PubMed ID: 37188743
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of the herbal formulations: molecular docking and molecular dynamics simulation studies to validate the efficacy of phytocompounds against SARS-CoV-2 proteins.
Joshi C; Chaudhari A; Joshi C; Joshi M; Bagatharia S
J Biomol Struct Dyn; 2022 Nov; 40(18):8405-8419. PubMed ID: 33988079
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening of natural compounds and inhibition of a major therapeutic target HsGSK-3β for Alzheimer's disease using computational approaches.
Shukla R; Singh TR
J Genet Eng Biotechnol; 2021 May; 19(1):61. PubMed ID: 33945025
[TBL] [Abstract][Full Text] [Related]
7. Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors.
Kumar P; Kumar D; Giri R
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31443266
[TBL] [Abstract][Full Text] [Related]
8. Identification of lead molecules against potential drug target protein MAPK4 from L. donovani: An in-silico approach using docking, molecular dynamics and binding free energy calculation.
Raj S; Sasidharan S; Dubey VK; Saudagar P
PLoS One; 2019; 14(8):e0221331. PubMed ID: 31425543
[TBL] [Abstract][Full Text] [Related]
9. Potential inhibitors for isocitrate lyase of Mycobacterium tuberculosis and non-M. tuberculosis: a summary.
Lee YV; Wahab HA; Choong YS
Biomed Res Int; 2015; 2015():895453. PubMed ID: 25649791
[TBL] [Abstract][Full Text] [Related]
10. Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from
Antil M; Gupta V
Protein Pept Lett; 2022; 29(12):1031-1041. PubMed ID: 36201276
[TBL] [Abstract][Full Text] [Related]
11. Structural and energetic understanding of novel natural inhibitors of Mycobacterium tuberculosis malate synthase.
Shukla R; Shukla H; Tripathi T
J Cell Biochem; 2019 Feb; 120(2):2469-2482. PubMed ID: 30206985
[TBL] [Abstract][Full Text] [Related]
12. Structure-based discovery of phenyl-diketo acids derivatives as
Shukla R; Shukla H; Tripathi T
J Biomol Struct Dyn; 2021 May; 39(8):2945-2958. PubMed ID: 32306850
[No Abstract] [Full Text] [Related]
13. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies.
Shukla R; Shukla H; Kalita P; Sonkar A; Pandey T; Singh DB; Kumar A; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2147-2162. PubMed ID: 28627969
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation.
Shukla R; Chetri PB; Sonkar A; Pakharukova MY; Mordvinov VA; Tripathi T
J Biomol Struct Dyn; 2018 Oct; 36(13):3541-3556. PubMed ID: 29029597
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
